These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31242643)

  • 1. Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of
    Cai L; Luo D; Yao B; Yang DM; Lin S; Girard L; DeBerardinis RJ; Minna JD; Xie Y; Xiao G
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31242643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC.
    Richtmann S; Wilkens D; Warth A; Lasitschka F; Winter H; Christopoulos P; Herth FJF; Muley T; Meister M; Schneider MA
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31083571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.
    Yamaura T; Ezaki J; Okabe N; Takagi H; Ozaki Y; Inoue T; Watanabe Y; Fukuhara M; Muto S; Matsumura Y; Hasegawa T; Hoshino M; Osugi J; Shio Y; Waguri S; Tamura H; Imai JI; Ito E; Yanagisawa Y; Honma R; Watanabe S; Suzuki H
    Oncol Lett; 2018 Feb; 15(2):1549-1558. PubMed ID: 29434849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
    Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
    Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
    Zhang J; Sun G; Mei X
    Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Yu J; Hou M; Pei T
    DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.
    Zang X; Chen M; Zhou Y; Xiao G; Xie Y; Wang X
    Cancer Inform; 2015; 14(Suppl 2):183-91. PubMed ID: 26052221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
    Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
    Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of
    Kim E; Wu HG; Keam B; Kim TM; Kim DW; Paeng JC; Kim HJ; Chang JH
    Clin Lung Cancer; 2019 Jan; 20(1):e9-e23. PubMed ID: 30266585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
    Goodwin J; Neugent ML; Lee SY; Choe JH; Choi H; Jenkins DMR; Ruthenborg RJ; Robinson MW; Jeong JY; Wake M; Abe H; Takeda N; Endo H; Inoue M; Xuan Z; Yoo H; Chen M; Ahn JM; Minna JD; Helke KL; Singh PK; Shackelford DB; Kim JW
    Nat Commun; 2017 May; 8():15503. PubMed ID: 28548087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LCE: an open web portal to explore gene expression and clinical associations in lung cancer.
    Cai L; Lin S; Girard L; Zhou Y; Yang L; Ci B; Zhou Q; Luo D; Yao B; Tang H; Allen J; Huffman K; Gazdar A; Heymach J; Wistuba I; Xiao G; Minna J; Xie Y
    Oncogene; 2019 Apr; 38(14):2551-2564. PubMed ID: 30532070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer.
    Chen Y; Liu Q; Chen Z; Wang Y; Yang W; Hu Y; Han W; Zeng H; Ma H; Dai J; Zhang H
    J Exp Clin Cancer Res; 2019 May; 38(1):193. PubMed ID: 31088500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
    Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
    Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies.
    Ho HL; Kao HL; Yeh YC; Chou TY
    Diagn Pathol; 2019 Jun; 14(1):59. PubMed ID: 31221183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of cytologic diagnosis of early lung cancer.
    Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
    Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
    Zhang JT; Lin YC; Xiao BF; Yu BT
    Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma.
    Zhou F; Wang X; Liu F; Meng Q; Yu Y
    Int J Clin Oncol; 2020 Sep; 25(9):1612-1623. PubMed ID: 32430734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
    Lu C; Chen H; Shan Z; Yang L
    Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.